Company: USPH
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001140361-25-013467
Chunk: 24

Company: U S PHYSICAL THERAPY INC /NV
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 24
---
 used in the calculation of these amounts are included in “Note 17 — Equity Based Plans” of the Notes to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K filed with SEC on March 3, 2025. |

| (3) | Effective May 16, 2024, Mr. Edward L. Kuntz was no longer a member of the Board of Directors. |

Compensation of Directors During 2024, each of our non-employee directors received a quarterly retainer fee (“Retainer Fee”) for serving as a member of our Board of Directors. The Retainer Fee was $16,250 per quarter. In addition, Lead Independent Director and Chair Fees were as follows: Lead Independent Director: $35,000; Chair of Audit Committee: $30,000; Chairs of Governance and Nominating Committee, Compensation Committee and Compliance Committee: $20,000. In addition, as noted above, in May 2024, each of the non-employee directors who were elected at the 2024 annual meeting received a grant of 1,424 shares of restricted stock under the terms of the Stock Incentive Plan. The restrictions on 356 shares of this grant lapsed on each of July 1, 2024, October 1, 2024, January 1, 2025 and April 1, 2025. The Board of Directors has not approved any further changes to director compensation thus far for 2025. Directors are also reimbursed for their out-of-pocket travel and related expenses incurred in attending Board and committee meetings.

15

TABLE OF CONTENTS

STOCK OWNERSHIP Stock Owned by Directors, Nominees and Executive Officers The following table shows the number and percentage of shares of our common stock beneficially owned by our directors, Named Executive Officers and all current directors and Executive Officers as a group as of April 10, 2025. Each person has sole voting and investment power for the shares shown below unless otherwise indicated.

| Name of Beneficial Owner                                             |     |       Number of 
 Shares Owned(1) |     | Percent of   
 Common Stock 
 Outstanding  |
| Directors:                                                           |     |                 |     |              |
| Christopher J. Reading                                               
 Chairman of the Board and Chief Executive Officer                    |     |      116,088(2) |     | 0.8%         |
| Kathleen A. Gilmartin                                                |     |          18,904 |